| TS group | HC group | p-value |
---|---|---|---|
Number | 30 | 30 | Â |
Gender (M/F) | 22/8 | 22/8 | 1.0 |
Age (yrs) (mean ± SD) | 9.28 ± 1.94 | 9.41 ± 1.91 | 0.657 |
FSIQ (mean ± SD) | 106.9 ± 9.31 | 109.6 ± 9.21 | 0.355 |
Dropout number (mean ± SD) | 16.4 ± 15.5 | 23.2 ± 28.1 | 0.255 |
Disease duration (yrs) (mean ± SD) | 2.1 ± 1.4 | NA |  |
VTS at present (mean ± SD, max: 25) | 5.1 ± 4.9 | NA |  |
VTS at the most severe condition (mean ± SD, max: 25) | 6.5 ± 4.3 | NA |  |
MTS at present (mean ± SD, max: 25) | 10.3 ± 3.9 | NA |  |
MTS at the most severe condition (mean ± SD, max: 25) | 11.6 ± 3.6 | NA |  |
TTS at present (mean ± SD, max: 50) | 15.3 ± 6.3 | NA |  |
TTS at the most severe condition (mean ± SD, max: 50) | 18.0 ± 5.7 | NA |  |